Title: A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.
Authors: Cohen, Stanley B.; Alten, Rieke; Kameda, Hideto; Hala, Tomas; Radominski, Sebastiao C.; Rehman, Muhammad I.; Palaparthy, Ramesh; Schumacher, Karl; Schmitt, Susanne; Hua, Steven Y.; Ianos, Claudia; Lea Sewell, K.
Publication: Arthritis Research & Therapy, 2018, Vol 20, Issue 1, pN.PAG
ISSN: 1478-6354
Publication type: Academic Journal
DOI: 10.1186/s13075-018-1646-4

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.

Cohen, Stanley B.; Alten, Rieke; Kameda, Hideto; Hala, Tomas; Radominski, Sebastiao C.; Rehman, Muhammad I.; Palaparthy, Ramesh; Schumacher, Karl; Schmitt, Susanne; Hua, Steven Y.; Ianos, Claudia; Lea Sewell, K.